Two major heavyweight events, "interest rate cuts + elections", have struck suddenly! Can the US stock market break the century-old curse of "September Hex"?
Since 1990, the average September decline of the S&P 500 index is 1.04%, with only a 47% chance of closing higher, performing far worse than other months.
The global interest rate cut cycle may start! Medical stocks in the US stock market are ready to explode. How to accurately capture the opportunity for skyrocketing?
AbbVie, AstraZeneca, Eli Lilly and Co, Intuitive Surgical, Novartis AG, and other pharmaceutical giants, as well as the robotic surgery giant Intuitive Surgical, have all reached record highs this year, with growth ranging from 18% to 64%, and even surpassing other technology giants except Nvidia.
Inflation cooling solidifies the expectation of Fed rate cuts! Will this industry become the new darling of Wall Street?
The SPDR S&P Biotech ETF (XBI) has achieved five consecutive gains, with a cumulative increase of nearly 8% in 5 days.
"Interest rate cuts + Trump's return" two major expectations continue to ferment! Will this benefiting sector see the dawn?
Market participants believe that in recent three years, the biotechnology sector has been underperforming the broader market. Once the expectation of interest rate cuts is raised by the Fed, biotechnology companies, represented by innovative drugs, will have the ability to make up ground.
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications